Submitted by mike kraft on
...
The mRNA-1283 vaccine showed a higher immune response—including in seniors—than its currently licensed vaccine, called mRNA-1273.222. Response was higher against Omicron BA.4/BA.5 as well as the original SARS-CoV-2 virus.
...
Submitted by mike kraft on
Submitted by mike kraft on
...
The Covid pandemic marked the first time people armed with powerful scientific tools could study how the immune system awakens to and develops defenses against a new threat, in real time, in the global population.
...
Submitted by mike kraft on
...
The FDA said in an email to CNN on Wednesday that it “has chosen to resolve this lawsuit rather than continuing to litigate over statements that are between two and nearly four years old.”
Submitted by mike kraft on
Submitted by mike kraft on
...
Transmission rates are still far below levels from 2022, when there were tens of thousands of cases in the US. But after a quieter year last year, experts say the US is vulnerable to increases in spread in a number of ways.
...
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
... high blood pressure may be a risk factor for developing the chronic condition. The study is published in BMJ Public Health.
...
Submitted by mike kraft on
New guidelines suggest certain high-risk groups could benefit from having another dose of a COVID-19 vaccine this spring — and more frequent shots in general — while the broader population could be entering once-a-year territory, much like an annual flu shot.
Medical experts told CBC News that falling behind on the latest shots can come with health risks, particularly for individuals who are older or immunocompromised.
:max_bytes(150000):strip_icc()/VWH-Annual-COVID-shot-plan-1-068de2012c8f47819e4cb74c76eb9143.jpg)
